Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lockhart

Showing results (241-250 of 338) with videos related to

Pageof 34
Sort By:
Antimicrobial Agents and Chemotherapy|December 12, 2018
The Fungal Cyp51-Specific Inhibitor VT-1598 Demonstrates <i>In Vitro</i> and <i>In Vivo</i> Activity against Candida aurisNathan P Wiederhold, Shawn R Lockhart, Laura K Najvar, et al.
The Lancet. Infectious Diseases|October 9, 2018
Multiple introductions and subsequent transmission of multidrug-resistant Candida auris in the USA: a molecular epidemiological surveyNancy A Chow, Lalitha Gade, Sharon V Tsay, et al.
BMC Microbiology|June 3, 2014
Real-time PCR assays for genotyping of Cryptococcus gattii in North AmericaErin J Kelley, Elizabeth M Driebe, Kizee Etienne, et al.
Medical Mycology|March 17, 2023
Whole-genome sequencing of Candida haemulonii species complex from Brazil and the United States: Genetic diversity and antifungal susceptibilityDality Keffelen de Barros Rodrigues, Shawn R Lockhart, Elizabeth L Berkow, et al.
Open Forum Infectious Diseases|June 5, 2024
Molecular and Epidemiological Investigation of Fluconazole-resistant <i>Candida parapsilosis</i>-Georgia, United States, 2021Elizabeth Misas, Lucy S Witt, Monica M Farley, et al.
Antimicrobial Agents and Chemotherapy|June 15, 2011
In vitro echinocandin susceptibility of Aspergillus isolates from patients enrolled in the Transplant-Associated Infection Surveillance NetworkShawn R Lockhart, Alicia J Zimbeck, John W Baddley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 10, 2017
Management of an Outbreak of Exophiala dermatitidis Bloodstream Infections at an Outpatient Oncology ClinicAmber Vasquez, D Zavasky, N A Chow, et al.
Journal of Clinical Microbiology|June 14, 2013
Preliminary laboratory report of fungal infections associated with contaminated methylprednisolone injectionsShawn R Lockhart, Cau D Pham, Lalitha Gade, et al.
Open Forum Infectious Diseases|November 3, 2022
Recurrent Candidemia: Trends and Risk Factors Among Persons Residing in 4 US States, 2011-2018Emma E Seagle, Brendan R Jackson, Shawn R Lockhart, et al.
Journal of Clinical Microbiology|May 13, 2011
Comparison of in vitro susceptibility characteristics of Candida species from cases of invasive candidiasis in solid organ and stem cell transplant recipients: Transplant-Associated Infections Surveillance Network (TRANSNET), 2001 to 2006Shawn R Lockhart, Debra Wagner, Naureen Iqbal, et al.
Pageof 34

Showing results (241-250 of 338) with videos related to

Sort By:
Pageof 34
Antimicrobial Agents and Chemotherapy|December 12, 2018
The Fungal Cyp51-Specific Inhibitor VT-1598 Demonstrates <i>In Vitro</i> and <i>In Vivo</i> Activity against Candida aurisNathan P Wiederhold, Shawn R Lockhart, Laura K Najvar, et al.
The Lancet. Infectious Diseases|October 9, 2018
Multiple introductions and subsequent transmission of multidrug-resistant Candida auris in the USA: a molecular epidemiological surveyNancy A Chow, Lalitha Gade, Sharon V Tsay, et al.
BMC Microbiology|June 3, 2014
Real-time PCR assays for genotyping of Cryptococcus gattii in North AmericaErin J Kelley, Elizabeth M Driebe, Kizee Etienne, et al.
Medical Mycology|March 17, 2023
Whole-genome sequencing of Candida haemulonii species complex from Brazil and the United States: Genetic diversity and antifungal susceptibilityDality Keffelen de Barros Rodrigues, Shawn R Lockhart, Elizabeth L Berkow, et al.
Open Forum Infectious Diseases|June 5, 2024
Molecular and Epidemiological Investigation of Fluconazole-resistant <i>Candida parapsilosis</i>-Georgia, United States, 2021Elizabeth Misas, Lucy S Witt, Monica M Farley, et al.
Antimicrobial Agents and Chemotherapy|June 15, 2011
In vitro echinocandin susceptibility of Aspergillus isolates from patients enrolled in the Transplant-Associated Infection Surveillance NetworkShawn R Lockhart, Alicia J Zimbeck, John W Baddley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 10, 2017
Management of an Outbreak of Exophiala dermatitidis Bloodstream Infections at an Outpatient Oncology ClinicAmber Vasquez, D Zavasky, N A Chow, et al.
Journal of Clinical Microbiology|June 14, 2013
Preliminary laboratory report of fungal infections associated with contaminated methylprednisolone injectionsShawn R Lockhart, Cau D Pham, Lalitha Gade, et al.
Open Forum Infectious Diseases|November 3, 2022
Recurrent Candidemia: Trends and Risk Factors Among Persons Residing in 4 US States, 2011-2018Emma E Seagle, Brendan R Jackson, Shawn R Lockhart, et al.
Journal of Clinical Microbiology|May 13, 2011
Comparison of in vitro susceptibility characteristics of Candida species from cases of invasive candidiasis in solid organ and stem cell transplant recipients: Transplant-Associated Infections Surveillance Network (TRANSNET), 2001 to 2006Shawn R Lockhart, Debra Wagner, Naureen Iqbal, et al.
Pageof 34